Asthma and other allergic diseases are caused by inappropriate immune responses. Soluble IgE molecules, produced by immune cells known as B cells, are key immune mediators of these diseases. A team of researchers has now developed a way to specifically eliminate IgE-producing B cells, providing a potential new long-lasting therapeutic approach to treat asthma and other allergic diseases.